The treatment of non-Hodgkin lymphoma in elderly patients
Salminen, E.
Duodecim; Laaketieteellinen Aikakauskirja 110(21): 1993-1998
1994
ISSN/ISBN: 0012-7183 PMID: 8654224 Document Number: 433549
Document emailed within 1 workday
Related Documents
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800Doorduijn, J.K.; Sonneveld, P. 1997: Diagnosis and treatment of non-Hodgkin lymphoma in elderly patients Nederlands Tijdschrift Voor Geneeskunde 141(45): 2152-2157
Brice, P.; Lepage, E.; Gisselbrecht, C.; Fior, R.; Trédaniel, J.; d'Agay, M.F.; Boiron, M. 1990: Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatment Nouvelle Revue Francaise D'hematologie 32(2): 153-157
Morrison, V.A. 2007: Non-Hodgkin's lymphoma in the elderly. Part 1: Overview and treatment of follicular lymphoma Oncology 21(9): 1104-1110
Merli, F.; Federico, M.; Avanzini, P.; Ilariucci, F.; Stelitano, C.; Iannitto, E.; Colombi, M.; Vallisa, D.; Santagati, G.; Picinini, L. 1998: Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi Haematologica 83(3): 217-221
Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44
Armitage, J.O. 2005: The treatment of patients with aggressive non-Hodgkin's lymphoma Oncology 19(4 Suppl 1: 3-6
Coiffier, B. 2008: The challenges of Hodgkin lymphoma in the elderly Oncology 22(12): 1388; 1393
Belić, A.; Popović, S.; Savić, I. 1992: Effect of polychemotherapy in the treatment of patients with non-Hodgkin's lymphoma Medicinski Pregled 45(5-6): 188-193
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91
Ali, J.; Siddiqui, N.; Hameed, A. 2016: Weight Changes in Patients with Hodgkin Lymphoma Following Treatment: Experience from a Cancer Hospital Journal of Ayub Medical College Abbottabad: Jamc 28(4): 738-741
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Zubrikhina, G.N.; Blindar, V.N.; Matveeva, I.I.; Demina, E.A. 2015: The characteristics of anemic syndrome in patients with prevalent phases of Hodgkin lymphoma before treatment Klinicheskaia Laboratornaia Diagnostika 60(2): 28-32
Gaudin, P.; Rozand, Y.; Fauconnier, J.; Phelip, X. 1995: Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma. A national survey of one hundred forty-six patients Revue du Rhumatisme 62(5): 365-375
Gisselbrecht, C.; Oksenjendler, E.; Tirelli, U.; Gabarre, J.; Gastaldi, R.; Farcet, J.P.; Thyss, A.; Coiffier, B.; Raphael, M.; Lepage, E. 1992: Non-Hodgkin's lymphoma associated with human immunodeficiency virus: treatment with LNH 84 regimen in a selected group of patients Leukemia 6(Suppl 3): 10s-11s
Baiocchi, O.C.G.; Colleoni, G.W.B.; Navajas, E.V.; Duarte, L.Claudio.C.; Alves, A.C.; Andrade, A.Lucia.S.S.; Kerbauy, J.; Oliveira, J.Salvador.R. 2002: Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma Acta Oncologica 41(2): 192-196
Somers, R.; van Heerde, P. 1983: Non-Hodgkin lymphoma in patients with Hodgkin's disease Nederlands Tijdschrift Voor Geneeskunde 127(2): 55-59
Hołowiecki, J.; Giebel, S.; Walewski, J.; Krawczyk-Kuliś, M.łg.; Hellmann, A.; Skotnicki, A.; Dmoszyńska, A.; Romejko, J.; Czyz, J.ła.; Jurczak, W.; Kachel, Łu.; Wojnar, J.; Stella-Hołowiecka, B.; Saduś-Wojciechowska, M.; Sułek, K.; Jedrzejczak, W.ła.; Robak, T.; Mariańska, B.; Szczylik, C.; Warzocha, K. 2003: Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. the experience of Polish lymphoma research group Polskie Archiwum Medycyny Wewnetrznej 110(2): 863-868
Landgren, O.; Algernon, C.; Axdorph, U.; Nilsson, B.; Wedelin, C.; Porwit-MacDonald, A.; Grimfors, G.; Björkholm, M. 2003: Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis Haematologica 88(4): 438-444